These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8989677)

  • 1. A primer of biostatistic and economic methods for diagnostic and prognostic modeling in nuclear cardiology: Part I.
    Shaw LJ; Hachamovitch R; Eisenstein EL; Kesler KL; Heller GV; Miller DD
    J Nucl Cardiol; 1996; 3(6 Pt 1):538-45. PubMed ID: 8989677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A primer of biostatistic and economic methods for diagnostic and prognostic modeling in nuclear cardiology: Part II.
    Shaw LJ; Eisenstein EL; Hachamovitch R; Heller GV; Miller DD
    J Nucl Cardiol; 1997; 4(1 Pt 1):52-60. PubMed ID: 9138840
    [No Abstract]   [Full Text] [Related]  

  • 3. Cost-effectiveness of nuclear cardiology.
    Maddahi J; Iskandrian AE
    J Nucl Cardiol; 1997; 4(2 Pt 2):S139-40. PubMed ID: 9115075
    [No Abstract]   [Full Text] [Related]  

  • 4. [Role of noninvasive examinations in the management of ischemic heart disease.IV. Nuclear cardiology in chronic ischemic heart disease].
    Candell Riera J; Bardají Ruiz A; Castell Conesa J; Jurado López JA; Magriñá Ballara J
    Rev Esp Cardiol; 1997 Feb; 50(2):83-91. PubMed ID: 9092007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the benefits of nuclear cardiology.
    Maisey M
    Q J Nucl Med; 1996 Mar; 40(1):47-54. PubMed ID: 8681013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnosis and prognosis of elderly patients with coronary artery disease: assessment with dipyridamole thallium imaging].
    Yamasaki F; Takata J; Seo H; Chikamori T; Yamada M; Yabe T; Doi Y
    J Cardiol; 1995 Oct; 26(4):219-26. PubMed ID: 7500264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term prediction of major ischemic events by exercise thallium-201 single-photon emission computed tomography. Incremental prognostic value compared with clinical, exercise testing, catheterization and radionuclide angiographic data.
    Marie PY; Danchin N; Durand JF; Feldmann L; Grentzinger A; Olivier P; Karcher G; Juillière Y; Virion JM; Beurrier D
    J Am Coll Cardiol; 1995 Oct; 26(4):879-86. PubMed ID: 7560612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival analysis for cardiac risk stratification.
    Nicolaidis C; Johnston B
    J Gen Intern Med; 1999 Jul; 14(7):451-3. PubMed ID: 10417607
    [No Abstract]   [Full Text] [Related]  

  • 9. Usefulness of serial radionuclide angiography in predicting cardiac death after coronary artery bypass grafting and comparison with clinical and cardiac catheterization data.
    Borges-Neto S; Shaw LJ; Kesler K; Sell T; Peterson ED; Coleman RE; Jones RH
    Am J Cardiol; 1997 Apr; 79(7):851-5. PubMed ID: 9104893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective risk stratification using exercise myocardial perfusion SPECT in women: gender-related differences in prognostic nuclear testing.
    Hachamovitch R; Berman DS; Kiat H; Bairey CN; Cohen I; Cabico A; Friedman J; Germano G; Van Train KF; Diamond GA
    J Am Coll Cardiol; 1996 Jul; 28(1):34-44. PubMed ID: 8752792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stress radionuclide imaging versus stress echocardiography: a framework for comparisons.
    Rozanski A; Gottdiener JS
    Prog Cardiovasc Dis; 2001; 43(4):275-9. PubMed ID: 11235844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear cardiology in private practice.
    Bateman TM
    J Nucl Cardiol; 1997; 4(2 Pt 2):S184-8. PubMed ID: 9115083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantifying the value of diagnostic tests.
    Lloyd JJ; Talbot PR; Lawson RS
    Nucl Med Commun; 1998 Oct; 19(10):999-1004. PubMed ID: 10234680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incremental prognostic value of RNA ejection fraction measurements during pharmacologic stress testing: a comparison with clinical and perfusion variables.
    Mast ST; Shaw LK; Ravizzini GC; Chambless M; Joski P; Coleman RE; Borges-Neto S
    J Nucl Med; 2001 Jun; 42(6):871-7. PubMed ID: 11390550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis by measurements of left ventricular function during exercise. Duke Noninvasive Research Working Group.
    Shaw LJ; Heinle SK; Borges-Neto S; Kesler K; Coleman RE; Jones RH
    J Nucl Med; 1998 Jan; 39(1):140-6. PubMed ID: 9443753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic analysis of clinical positron emission tomography of the heart with rubidium-82.
    Gould KL; Goldstein RA; Mullani NA
    J Nucl Med; 1989 May; 30(5):707-17. PubMed ID: 2785587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of nuclear cardiology in clinical decision making.
    Berman DS; Germano G; Shaw LJ
    Semin Nucl Med; 1999 Oct; 29(4):280-97. PubMed ID: 10534232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ¹²³I-MIBG Imaging for Prediction of Mortality and Potentially Fatal Events in Heart Failure: The ADMIRE-HFX Study.
    Narula J; Gerson M; Thomas GS; Cerqueira MD; Jacobson AF
    J Nucl Med; 2015 Jul; 56(7):1011-8. PubMed ID: 26069309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological stress testing.
    Travain MI; Wexler JP
    Semin Nucl Med; 1999 Oct; 29(4):298-318. PubMed ID: 10534233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Independent and incremental prognostic value of tests performed in hierarchical order to evaluate patients with suspected coronary artery disease. Validation of models based on these tests.
    Pollock SG; Abbott RD; Boucher CA; Beller GA; Kaul S
    Circulation; 1992 Jan; 85(1):237-48. PubMed ID: 1728455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.